220Curated trials
Enterprise Evidence Report · NR-REPORT-V2.0
Australia
Neuroscience Intelligence
Australia neuroscience evidence report: current clinical, research, institution and source-linked intelligence.
Evidence rank #9 of 50 · Data maturity A · Research score 45.6 · Data confidence 100.0 / 100 · Snapshot 2026-10-29 06:18 UTC.
69Recruiting trials
558Publications
236Institutions
Executive interpretation
Australia ranks #9 in the current NeuroRisk evidence-ranked market layer. This ranking summarizes indexed clinical, publication and institution evidence; it is not a probability of commercial success and not an investment recommendation.
Methodology status
Methodology NR-REPORT-V2.0. Clinical metrics and NCT evidence use only records classified as in_scope or related; out_of_scope records remain preserved outside these analytical counts. No synthetic ML confidence is presented as scientific probability. Counts and source links below are tied to the generation snapshot.
Methodology →Leading sponsors
Merck Sharp & Dohme LLC2511 recruiting
Hoffmann-La Roche144 recruiting
Pfizer61 recruiting
Biogen62 recruiting
Eli Lilly and Company60 recruiting
Novartis Pharmaceuticals62 recruiting
AbbVie50 recruiting
Fenix Innovation Group42 recruiting
Eisai Inc.42 recruiting
The University of Queensland41 recruiting
Disease activity
Alzheimers53trials
Parkinsons40trials
Epilepsy33trials
Stroke13trials
Autism13trials
Neuromuscular10trials
Other Neurology10trials
Depression9trials
Multiple Sclerosis9trials
Schizophrenia5trials
Research institutions
Sutherland HospitalOpenAlexlinked institution
Sydney Children's HospitalOpenAlexlinked institution
Women's and Children's HospitalOpenAlexlinked institution
Central Adelaide Local Health NetworkOpenAlexlinked institution
Autism CRCOpenAlexlinked institution
Adelaide UniversityOpenAlexlinked institution
Monash Medical CentreOpenAlexlinked institution
Addiction and Mental Health Services - MSHOpenAlexlinked institution
Anzac Research InstituteOpenAlexlinked institution
Queen Elizabeth II Medical CentreOpenAlexlinked institution
Clinical evidence trail
NCT07424404A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and AdolescentsRECRUITING
NCT07369076A Clinical Trial to Evaluate NB-4746 in Participants With Amyotrophic Lateral Sclerosis.RECRUITING
NCT07304154A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic DiseasesRECRUITING
NCT07257978Efficacy and Safety of NTI164 in Children and Young Adults With Rett SyndromeNOT_YET_RECRUITING
NCT07238868An Open-label Study to Evaluate Safety, Tolerability, and Efficacy of CB03-154 in Subjects Diagnosed With EpilepsyRECRUITING
NCT07221669A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA)RECRUITING
NCT07174310A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's DiseaseRECRUITING
Research evidence trail
PUBMEDProspective associations of depression and anxiety symptoms with the transition from suicidal ideation to attempt over 18 months.2026-12-15
PUBMEDOn Signs and Symptoms: A Manifesto on the Clinical Examination of the Disturbed Mind.2026-12-01
PUBMEDAttention and Its Symptoms: From Descriptive Psychopathology to RDoC and Back Again.2026-12-01
PUBMEDComplex post-traumatic stress disorder in refugees, asylum seekers, and internally displaced people: a systematic review and meta-analysis.2026-12-01
PUBMEDBeyond Face Value: The Clinical Significance of Facial Morphology and Expression in Neuropsychiatry.2026-12-01
PUBMEDStress-reducing activities in multiple sclerosis: Determinants of engagement and associations with 5-year clinical outcomes and quality of life.2026-12-01
PUBMEDA capability-stratified framework for high-grade glioma care: A domain-level analysis across the Asia-Pacific Region.2026-12-01
PUBMEDUnderstanding mental health needs in Ukraine: protocol for a longitudinal survey of mental health in children and caregivers during the war in Ukraine.2026-12-01
PUBMEDCognitive trajectories in the nine months following recent-onset major depressive disorder.2026-12-01
World Bank context
Macro indicators are shown only where a timestamped World Bank source row exists. Latest collection in this report: 2026-10-24 04:18 UTC. They are context, not NeuroRisk predictions.
Sources and provenance
ClinicalTrials.gov provides NCT evidence. PubMed/NCBI and OpenAlex provide research metadata. OpenAlex links institutions. World Bank indicators are included only when an explicit source row and year exist. NeuroRisk transformations add normalization, ranking and graph connections.
Limitations
Indexed corpus counts are not guaranteed exhaustive global totals. Scores are comparative decision-support signals. This report is not medical advice, regulatory advice, patent clearance, an investment recommendation or a guarantee of outcome.